Sanofi, Novo, Lilly Look To Ditch Minn. AG's Insulin Suit

By Bryan Koenig (August 13, 2019, 6:28 PM EDT) -- Sanofi-Aventis U.S. LLC, Novo Nordisk Inc. and Eli Lilly and Co. urged a New Jersey federal judge Monday to toss the Minnesota attorney general's insulin pricing lawsuit against them, arguing that the racketeering allegations of deceptive prices are undone by Minnesota law and the state's own practices....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!